June 29, 2022

News

News Network

DFC Announces Financing to Support COVID-19 Vaccine Manufacturing in South Africa

1 min read

Ned Price, Department Spokesperson

Today, the U.S. International Development Finance Corporation (DFC) announced a joint financing package of €600 million for Aspen Pharmacare Holdings Ltd., headquartered in South Africa, to expand local vaccine manufacturing capacity.  DFC is working together with DEG (Germany), Proparco (France), and the International Finance Corporation (IFC) to provide financing support.  The package will help increase capacity to support Aspen’s efforts to produce COVID-19 vaccines with Stringent Regulatory Authorization (SRA) and/or World Health Organization (WHO) Emergency Use Listing, including the Johnson & Johnson COVID-19 vaccine.

The vaccines will be primarily distributed to the African Union, South African Government, and COVAX.

This effort supports the Administration’s goal to scale vaccine production, invest in African ingenuity and resilience, and help the global community beat this COVID-19 pandemic.

More from: Ned Price, Department Spokesperson

Crime ACN News Network

Network News © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © ACN 2020

ACN Privacy Policies
ACN TOS
Area Control Network (ACN)
Area Control Network
Area Control Network Center